On average PJT/EVR exits similar to Citi/BofA but still well below GS/MS/JPM. However, if you have a strong profile anything can happen even from DB/UBS/Barclays
Really is not true sadly. The following arguments will be considering proportion. PJT on a distressed / credit basis, exits the best in the entirety of London. On an opportunistic basis, they exit the best out of all EB's and similarly to mid-tier BB. EVR, even when considering proportions, is still more similar overall to DB et al. PJT, on a buyout basis, is more similar to DB et al. too. Pretty clear why, but if still you don't understand, I shall elaborate.
But yes you are right, the brand thing can be overblown at times. If you are exceptional, you can pull off anything. EVR RX is not even a top 4 player in EMEA yet they still had an impressive exit this year.
For most groups, Citi/BofA is stronger than EVR/PJT M&A, given how conservative Europe is, and the subsequent weighting of financing in winning mandates (both Citi/BofA avg. deal value is over €2bn, PJT/EVR is around €1bn). Would only consider taking these EBs when it's their top groups vs. a weak group at these BBs.
Overall the consensus seems to be that RX exits much better on a per capita basis, friend there confirmed that they get exponentially more HH inbounds than their M&A counterparts
Smaller pool to choose from for select Credit / Distressed / Opportunistic opps. You have ~5-6 notable banks with decent group sizes operating within something adjacent to that domain and maybe a dozen or so other levfin guys at the BB's. Smaller pool of talent than vanilla buyout with proportionately a higher level of spots (everyone and their grandma is trying to expand to some of these strategies) = Higher likelihood of HH inbounds. You can't just hire everyone from PJT.
Repudiandae sunt eum aliquam. Quidem velit vitae voluptatem ea ut ex suscipit. Mollitia enim expedita ex nihil quia. Et incidunt praesentium omnis laboriosam impedit.
Voluptates et maxime odit nulla sunt. Totam voluptate velit quidem itaque repellat consequuntur minus. Nulla praesentium tempore eaque et. Facilis aut suscipit aut possimus at. Non repellendus in asperiores esse et.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
Sorry, you need to login or sign up in order to vote. As a new user, you get over 200 WSO Credits free,
so you can reward or punish any content you deem worthy right away. See you on the other side!
in 2024. MFs: 1-2. UMM: A few
2024: Hg, Centerbridge, HIG, TDR, GIP, HPS, Charterhouse, Montagu some more I can’t remember.
Two guys left the tech team to start an AI-based app
previous years have exited to top MFs CVC, Apax, SLP, Advent, EQT, Ares, Oaktree etc
are these good numbers in london? I hear they where getting very good exits
Very good for their analyst class size (~25 in M&A)
how are the top 5 EB (pjt/evr/laz/roths/cvp) exits compared to mid tier BB (citi, bofa, barclays) and to top tier BB (gs/jpm/ms) in london?
On average PJT/EVR exits similar to Citi/BofA but still well below GS/MS/JPM. However, if you have a strong profile anything can happen even from DB/UBS/Barclays
Really is not true sadly. The following arguments will be considering proportion. PJT on a distressed / credit basis, exits the best in the entirety of London. On an opportunistic basis, they exit the best out of all EB's and similarly to mid-tier BB. EVR, even when considering proportions, is still more similar overall to DB et al. PJT, on a buyout basis, is more similar to DB et al. too. Pretty clear why, but if still you don't understand, I shall elaborate.
But yes you are right, the brand thing can be overblown at times. If you are exceptional, you can pull off anything. EVR RX is not even a top 4 player in EMEA yet they still had an impressive exit this year.
Top 3 BBs are always best in London (RX aside).
For most groups, Citi/BofA is stronger than EVR/PJT M&A, given how conservative Europe is, and the subsequent weighting of financing in winning mandates (both Citi/BofA avg. deal value is over €2bn, PJT/EVR is around €1bn). Would only consider taking these EBs when it's their top groups vs. a weak group at these BBs.
Overall the consensus seems to be that RX exits much better on a per capita basis, friend there confirmed that they get exponentially more HH inbounds than their M&A counterparts
Smaller pool to choose from for select Credit / Distressed / Opportunistic opps. You have ~5-6 notable banks with decent group sizes operating within something adjacent to that domain and maybe a dozen or so other levfin guys at the BB's. Smaller pool of talent than vanilla buyout with proportionately a higher level of spots (everyone and their grandma is trying to expand to some of these strategies) = Higher likelihood of HH inbounds. You can't just hire everyone from PJT.
Bump. Following
Repudiandae sunt eum aliquam. Quidem velit vitae voluptatem ea ut ex suscipit. Mollitia enim expedita ex nihil quia. Et incidunt praesentium omnis laboriosam impedit.
Voluptates et maxime odit nulla sunt. Totam voluptate velit quidem itaque repellat consequuntur minus. Nulla praesentium tempore eaque et. Facilis aut suscipit aut possimus at. Non repellendus in asperiores esse et.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...